Mazen Hanna,Ning Shan,Miranda L. Cheney,David R. Weyna
申请号：
US13399730
公开号：
US20120149692A1
申请日:
2012.02.17
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The invention is directed to novel crystalline forms of meloxicam. These novel crystalline forms of meloxicam have improved bioavailability, an enhanced rate of dissolution and shorter time to Cmax in blood, as compared to pure meloxicam.
